Abstract A66: Analytical validation of 7 droplet digital PCR assays detecting TERT, BRAF, and NRAS hotspot mutations in plasma-derived circulating tumor DNA (ctDNA)
Mahrukh M. Syeda(NYU Langone Health), David Polsky(New York University), Broderick C. Corless(Cornell University), George Karlin‐Neumann(Bio-Rad (United States)), Cindy Spittle(SunEdison (United States)), Iman Osman(New York University)
Cited by 2
Related Papers
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
|Analytical Chemistry|2011|2.8k
BRAF mutation predicts sensitivity to MEK inhibition
|Nature|2005|1.3k
Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment
|Nature Genetics|2022|527
Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
|Clinical Cancer Research|2008|188
Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma
|Clinical Cancer Research|2020|177